Chapter 29: The Child with Endocrine Dysfunction

Chapter 29: The Child with Endocrine Dysfunction

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

MULTIPLE CHOICE

 

1. Parents of a toddler with hypopituitarism ask the nurse, “What can we expect with this condition?” The nurse should respond with which statement?

a.	Growth is normal during the first 3 years of life.
b.	Weight is usually more retarded than height.
c.	Skeletal proportions are normal for age.
d.	Most of these children have subnormal intelligence.

 

 

ANS:  C

In children with hypopituitarism, the skeletal proportions are normal. Growth is within normal limits for the first year of life. Height is usually more delayed than weight. Intelligence is not affected by hypopituitarism.

 

PTS:   1                    DIF:    Cognitive Level: Apply                   REF:   977

TOP:   Integrated Process: Teaching/Learning

MSC:  Area of Client Needs: Physiologic Integrity: Physiologic Adaptation

 

2. A child with hypopituitarism is being started on growth hormone (GH) therapy. Nursing considerations should be based on which knowledge?

a.	Treatment is most successful if it is started during adolescence.
b.	Treatment is considered successful if children attain full stature by adulthood.
c.	Replacement therapy requires daily subcutaneous injections.
d.	Replacement therapy will be required throughout the child’s lifetime.

 

 

ANS:  C

Additional support is required for children who require hormone replacement therapy, such as preparation for daily subcutaneous injections and education for self-management during the school-age years. Young children, obese children, and those who are severely GH deficient have the best response to therapy. When therapy is successful, children can attain their actual or near-final adult height at a slower rate than their peers. Replacement therapy is not needed after attaining final height. They are no longer GH deficient.

 

PTS:   1                    DIF:    Cognitive Level: Analyze                REF:   978

TOP:   Integrated Process: Nursing Process: Planning

MSC:  Area of Client Needs: Physiologic Integrity: Pharmacologic and Parenteral Therapy

 

3. A child with growth hormone (GH) deficiency is receiving GH therapy. When is the best time for the GH to be administered?

a.	At bedtime
b.	After meals
c.	Before meals
d.	On arising in the morning

 

 

ANS:  A

Injections are best given at bedtime to more closely approximate the physiologic release of GH. After or before meals and on arising in the morning do not mimic the physiologic release of the hormone.

 

PTS:   1                    DIF:    Cognitive Level: Apply                   REF:   979

TOP:   Integrated Process: Nursing Process: Implementation

MSC:  Area of Client Needs: Physiologic Integrity: Pharmacologic and Parenteral Therapy

 

4. An adolescent is being seen in the clinic for evaluation of acromegaly. The nurse understands that which occurs with acromegaly?

a.	There is a lack of growth hormone (GH) being produced.
b.	There is excess growth hormone (GH) after closure of the epiphyseal plates.
c.	There is an excess of growth hormone (GH) before the closure of the epiphyseal plates.
d.	There is a lack of thyroid hormone being produced.

 

 

ANS:  B

Excess GH after closure of the epiphyseal plates results in acromegaly. A lack of growth hormone results in delayed growth or even dwarfism. Gigantism occurs when there is hypersecretion of GH before the closure of the epiphyseal plates. Cretinism is associated with hypothyroidism.

 

PTS:   1                    DIF:    Cognitive Level: Understand            REF:   979

TOP:   Integrated Process: Nursing Process: Assessment

MSC:  Area of Client Needs: Physiologic Integrity: Reduction of Risk Potential

 

5. A child will start treatment for precocious puberty. The nurse recognizes that this will involve the injection of which synthetic medication?

a.	Thyrotropin
b.	Gonadotropins
c.	Somatotropic hormone
d.	Luteinizing hormone–releasing hormone

 

 

ANS:  D

Precocious puberty of central origin is treated with monthly subcutaneous injections of luteinizing hormone–releasing hormone. Thyrotropin, gonadotropins, and somatotropic hormone are not the appropriate therapies for precocious puberty.

 

PTS:   1                    DIF:    Cognitive Level: Understand            REF:   980

TOP:   Integrated Process: Nursing Process: Implementation

MSC:  Area of Client Needs: Physiologic Integrity: Pharmacologic and Parenteral Therapy